Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +1.69% | +24.53% | -53.91% |
15/05 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
15/05 | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.91% | 4.29Cr | |
+32.09% | 69TCr | |
+29.39% | 58TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- CASI Stock
- News CASI Pharmaceuticals, Inc.
- CASI Pharmaceuticals, BioInvent Dose First Patient in Trial of Combination Treatment for Non-Hodgkin's Lymphoma